Suppr超能文献

全球范围内对植入前基因检测的监管:国际政策与伦理视角比较

Regulating Preimplantation Genetic Testing across the World: A Comparison of International Policy and Ethical Perspectives.

作者信息

Ginoza Margaret E C, Isasi Rosario

机构信息

University of Miami Miller School of Medicine, Miami, Florida 33136, USA.

Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.

出版信息

Cold Spring Harb Perspect Med. 2020 May 1;10(5):a036681. doi: 10.1101/cshperspect.a036681.

Abstract

Preimplantation genetic testing (PGT) is a reproductive technology that, in the course of in vitro fertilization (IVF), allows prospective parents to select their future offspring based on genetic characteristics. PGT could be seen as an exercise of reproductive liberty, thus potentially raising significant socioethical and legal controversy. In this review, we examine-from a comparative perspective-variations in policy approaches to the regulation of PGT. We draw on a sample of 19 countries (Australia, Austria, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Italy, Japan, Mexico, Netherlands, Singapore, South Korea, Switzerland, United Kingdom, and the United States) to provide a global landscape of the spectrum of policy and legislative approaches (e.g., restrictive to permissive, public vs. private models). We also explore central socioethical and policy issues and contentious applications, including permissibility criteria (e.g., medical necessity), nonmedical sex selection, and reproductive tourism. Finally, we further outline genetic counseling requirements across policy approaches.

摘要

植入前基因检测(PGT)是一种生殖技术,在体外受精(IVF)过程中,它使准父母能够根据基因特征选择未来的后代。PGT可被视为一种生殖自由的行为,因此可能引发重大的社会伦理和法律争议。在本综述中,我们从比较的角度审视了PGT监管政策方法的差异。我们选取了19个国家(澳大利亚、奥地利、比利时、巴西、加拿大、中国、法国、德国、印度、以色列、意大利、日本、墨西哥、荷兰、新加坡、韩国、瑞士、英国和美国)作为样本,以呈现政策和立法方法范围的全球概况(例如,从限制到许可,公共模式与私人模式)。我们还探讨了核心的社会伦理和政策问题以及有争议的应用,包括许可标准(如医疗必要性)、非医学性别选择和生殖旅游。最后,我们进一步概述了不同政策方法下的遗传咨询要求。

相似文献

3
Regulatory approaches to reproductive genetic testing.生殖基因检测的监管方法。
Hum Reprod. 2004 Dec;19(12):2695-701. doi: 10.1093/humrep/deh505. Epub 2004 Sep 23.

引用本文的文献

1
The clinical application and challenges of preimplantation genetic testing.胚胎植入前基因检测的临床应用与挑战
Front Genet. 2025 Jun 2;16:1599088. doi: 10.3389/fgene.2025.1599088. eCollection 2025.
6
Polygenic embryo screening: quo vadis?多基因胚胎筛查:路在何方?
J Assist Reprod Genet. 2024 Jul;41(7):1719-1726. doi: 10.1007/s10815-024-03169-8. Epub 2024 Jun 15.
7
Preimplantation Genetic Testing within the Public Healthcare System in Slovenia.斯洛文尼亚公共医疗体系中的植入前基因检测
Balkan J Med Genet. 2024 Mar 12;26(2):5-10. doi: 10.2478/bjmg-2023-0017. eCollection 2023 Dec.
9
Novel embryo selection strategies-finding the right balance.新型胚胎选择策略——寻求恰当平衡
Front Reprod Health. 2023 Dec 15;5:1287621. doi: 10.3389/frph.2023.1287621. eCollection 2023.

本文引用的文献

2
Contested change: how Germany came to allow PGD.有争议的变革:德国如何开始允许实施胚胎植入前基因诊断
Reprod Biomed Soc Online. 2016 Dec 13;3:60-67. doi: 10.1016/j.rbms.2016.11.002. eCollection 2016 Dec.
8
Pre-implantation HLA matching: The production of a Saviour Child.胚胎植入前 HLA 配型:制造救世主婴儿。
Best Pract Res Clin Obstet Gynaecol. 2017 Oct;44:76-89. doi: 10.1016/j.bpobgyn.2017.05.008. Epub 2017 Jun 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验